Evolent Health Stock Target Price and Analyst Consensus
| EVH Stock | USD 9.44 1.03 9.84% |
The current analyst and expert consensus on Evolent Health is Strong Buy, with 10 strong buy opinions. The current projected Evolent Health target price consensus is 23.75 with 16 analyst opinions. Check out Macroaxis Advice on Evolent Health to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.The most common way Evolent Health analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Evolent Health executives and customers to further validate their buy or sell advice. Evolent Health buy-or-sell recommendation module provides average expert sentiment on the projected Evolent Health target price to derive its highest and lowest estimates based on projected price volatility of 3.1692.
Lowest Forecast 21.61 | Highest Forecast 26.36 | Target Price 23.75 |
Evolent |
It's important to approach Evolent Health's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Evolent Health Target Price Consensus
Evolent target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Evolent Health's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 16 | Strong Buy |
Most Evolent analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Evolent stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Evolent Health, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationEvolent Health Target Price Projection
Evolent Health's current and average target prices are 9.44 and 23.75, respectively. The current price of Evolent Health is the price at which Evolent Health is currently trading. On the other hand, Evolent Health's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Evolent Health Market Quote on 26th of February 2025
Target Price
Analyst Consensus On Evolent Health Target Price
Evolent Health Analyst Ratings
Evolent Health's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Evolent Health stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Evolent Health's financials, market performance, and future outlook by experienced professionals. Evolent Health's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Evolent Health price targets
Evolent Health's stock target price is an estimate of its future price, usually made by analysts. Using Evolent Health's target price to determine if it is a suitable investment can be done through the following steps:- Look at Evolent Health's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Evolent Health's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Evolent Health Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Evolent Health is a key component of Evolent Health valuation and have some predictive power on the future returns of a Evolent Health.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Evolent Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Hedge Favorites Invested few shares | |
 | Banking Invested over 30 shares | |
 | Driverless Cars Invested over 60 shares | |
 | Cash Cows Invested few shares | |
 | Investor Favorites Invested over 60 shares | |
 | Dividend Beast Invested over 60 shares | |
 | Blockchain Invested few shares | |
 | Momentum Invested over 300 shares | |
 | Chemicals Invested over 30 shares | |
 | Artificial Intelligence Invested few shares | |
 | Robots And Drones Invested over 20 shares |
Check out Macroaxis Advice on Evolent Health to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.